Welcome to our dedicated page for Coca-Cola Europacific Partners Plc SEC filings (Ticker: CCEP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Coca-Cola Europacific Partners plc (CCEP) SEC filings page on Stock Titan brings together the company’s U.S. regulatory disclosures, primarily filed on Form 20-F and Form 6-K as a foreign private issuer. These documents cover a wide range of information, from annual reports and audited financial statements to interim trading updates, capital markets announcements, share buyback activity and governance changes.
In its Form 20-F annual report and related filings, CCEP presents detailed financial statements and notes for the year, including revenue, volume in unit cases, revenue per unit case, operating profit and comparable free cash flow. Investors can also review discussions of alternative performance measures such as comparable and adjusted comparable results, and FX-neutral metrics, which CCEP uses to illustrate underlying trends across its European and APS segments.
Frequent Form 6-K submissions include quarterly trading updates, interim dividend declarations, and lists of public announcements required under the UK Financial Conduct Authority’s Disclosure Guidance and Transparency Rules. Many of these 6-Ks reproduce the same trading tables and commentary found in CCEP’s market releases, providing SEC-registered access to information on category performance, channel trends, guidance for revenue and operating profit growth, and capital expenditure plans.
Other 6-K filings document transactions in CCEP’s own shares under its share buyback programme, specifying daily repurchase volumes and prices across US and UK trading venues, with repurchased shares to be cancelled. Governance-related filings report Board succession planning and director appointments, as well as notifications of total voting rights and PDMR share dealings.
On Stock Titan, AI-powered tools can help summarise lengthy CCEP filings, highlight key figures and definitions, and surface items such as dividend payout ratios, share repurchase authorisations and index-related disclosures. Real-time ingestion from EDGAR means new CCEP 6-Ks and 20-Fs appear promptly, while structured views of Form 6-K content make it easier to track recurring elements like trading updates, guidance revisions and buyback progress.
Coca-Cola Europacific Partners reported preliminary unaudited full-year 2025 results showing modest top-line growth and stronger profitability. Revenue rose to €20.9 billion, up 2.3% as reported and 4.1% on a fx-neutral basis, with volume up 2.4% to 3,958 million unit cases.
Reported operating profit increased to €2.8 billion, up 31.0%, while comparable operating profit grew 5.4%. Diluted EPS climbed to €4.26 from €3.08, with comparable EPS at €4.11. The dividend per share was €2.04, maintaining about a 50% payout ratio, and a 2025 share buyback of €1,006 million reduced shares in issue. Net debt was €9.8 billion, slightly higher than 2024, and the group continued restructuring and efficiency programs to manage inflationary pressures.
Coca-Cola Europacific Partners plans to return up to €1bn to shareholders through a coordinated share buyback programme across US and London trading venues. The programme will start on 18 February 2026 and is expected to complete before the end of February 2027, with all repurchased shares cancelled to reduce the company’s issued share capital.
An initial tranche is expected to run until no later than 30 June 2026, with purchases of up to €500,000,000, including up to €130,000,000 on London trading venues. For this initial period, the maximum number of ordinary shares that may be purchased or committed is 35,017,269, subject to existing and renewed shareholder authorities.
Coca-Cola Europacific Partners reported strong preliminary 2025 results, with revenue of
Diluted EPS reached
The company announced a further share buyback programme of up to
Coca-Cola Europacific Partners plc filed a report describing routine share dealings by senior managers and updating its share capital. Several executives, including the Chief Financial Officer and regional general managers, acquired small numbers of ordinary shares of €0.01 each in January 2026 under employee share purchase and UK share plans, some at market prices around USD $88.80 and some at no cost following vesting of matching awards from an employee benefit trust.
As of 31 January 2026, the company had 449,091,063 ordinary shares in issue, each carrying one vote, with no shares held in treasury, giving a total of 449,091,063 voting rights for disclosure calculations.
Coca-Cola Europacific Partners plc is planning a Board transition, with Independent Non-Executive Director and Senior Independent Director Thomas Johnson retiring at the conclusion of the Annual General Meeting on 28 May 2026 after around a decade of service. He has held key roles on the Environmental, Social and Governance, Remuneration, Nomination and Affiliated Transaction Committees, and is credited with helping guide the company through significant transformation since the merger.
As part of its succession planning, the Board has approved the appointment of Laurence Debroux as an Independent Non-Executive Director, effective from the end of the same AGM on 28 May 2026. The Board has determined she is independent under the UK Corporate Governance Code. Debroux brings extensive finance and governance experience from senior roles at Heineken, JCDecaux and SANOFI, and currently serves on the boards and audit committees of EXOR N.V. and Randstad N.V. The Nomination Committee will review Board committee compositions and the next Senior Independent Director appointment and will provide further details later.
Coca-Cola Europacific Partners plc reports a series of December 2025 transactions in its own ordinary shares under its previously announced share buyback programme. On dates including 9 December 2025 and 15 December 2025, the company repurchased ordinary shares on US Trading Venues and, on most days, on London Trading Venues, such as 36,817 shares on US venues and 24,449 shares on London venues on 9 December 2025, and 37,600 shares on US venues on 15 December 2025. The repurchased ordinary shares will be cancelled.
These purchases form part of the Programme announced on 14 February 2025, under which the company expects to repurchase up to EUR 1 billion of ordinary shares in aggregate. For the final tranche of the Programme, the aggregate amount of purchases is stated as EUR 382,000,000, and the company notes that the amount in respect of the US Trading Venues has been increased from EUR 280,000,000 to EUR 280,394,000 while the overall tranche size remains the same, with purchases on US venues expected to be completed by 19 December 2025.
Coca-Cola Europacific Partners plc (CCEP) has filed a Form 6-K summarising routine share repurchases under its previously announced buyback programme.
The company reports daily purchases of its own ordinary shares between 18 and 24 November 2025 on US trading venues, with additional London market purchases on 24 November 2025, including 36,600 shares on US venues and 24,645 shares across London venues that day. All repurchased shares will be cancelled, reducing the share count over time.
These transactions are part of a wider programme announced on 14 February 2025, under which CCEP expects to repurchase up to EUR 1 billion of ordinary shares in aggregate. The filing notes that the announcements are informational and do not constitute an offer or solicitation to buy or sell securities.
Coca-Cola Europacific Partners plc (CCEP) provides an update on shareholder voting at its 2025 Annual General Meeting, focusing on the Rule 9 waiver linked to its share buyback authority. All resolutions at the AGM were passed, but the Rule 9 Waiver Resolution received lower support, with 74.95% of votes cast in favour, compared with very high approval for related buyback authorities in resolutions 27 and 28, at 99.22% and 98.22% respectively.
The Rule 9 waiver allows CCEP to continue repurchasing its own shares without triggering a mandatory takeover offer by Olive Partners, S.A. if its ownership percentage rises due to buybacks. The Board links this to its previously announced commitment to return up to €1bn to shareholders via share buybacks and states that buybacks are a core element of its capital allocation framework. The Board acknowledges shareholder concerns about Rule 9 waivers, notes ongoing engagement with investors, and says it continues to consider alternative ways of returning capital.
Coca-Cola Europacific Partners plc (CCEP) reports a series of share repurchases in November 2025 under its share buyback programme of up to EUR 1 billion of ordinary shares. The company states that all repurchased shares will be cancelled.
On 11 November 2025, CCEP purchased 71,676 ordinary shares on US trading venues at prices between USD 91.9900 and USD 93.3600 per share, and 34,000 ordinary shares on London trading venues. On 12 November 2025, it bought 69,878 ordinary shares on US trading venues and 34,000 on London venues, followed by 70,701 and 20,000 ordinary shares respectively on 13 November 2025.
Further purchases included 72,285 ordinary shares on US trading venues and 15,350 on London venues on 14 November 2025, and 72,183 ordinary shares on US trading venues on 17 November 2025. The repurchases took place across Nasdaq and other US venues, as well as the London Stock Exchange, CBOE Europe and Aquis.
Coca-Cola Europacific Partners (CCEP) filed a Form 6-K reporting daily share repurchases carried out between 4 and 10 November 2025 under its buyback programme, under which the company expects to repurchase up to EUR 1 billion of ordinary shares. All repurchased shares will be cancelled. Purchases were executed on US Trading Venues (including Nasdaq) via Jefferies LLC and on London Trading Venues via Jefferies International Limited.
Disclosed daily activity: on 4 Nov, 75,415 shares on US venues and 34,000 on London venues; on 5 Nov, 74,660 (US) and 34,000 (London); on 6 Nov, 73,944 (US) and 34,000 (London); on 7 Nov, 73,606 (US) and 33,958 (London); on 10 Nov, 71,388 (US) and 32,000 (London). The disclosures include venue-level highest, lowest and volume‑weighted average prices for each day.